January, 2023
13 biotech companies to discover in the Swiss Health Valley in 2023
By Jim Cornall, in Labiotech.eu
July, 2022
Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study
By Einar Stefansson et al. Published by Acta Ophthalmologica
July, 2022
Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease
By Lee Shettle et al., Published by Clinical Ophthalmology
April, 2022
2023 Will Be Pivotal Year for Oculis’ Potentially Transformative Medicines
By Gail Dutton in Biospace
December, 2021
The Diabetic Eye Disease Pipeline in 2021
By Xuejing Chen, Arshad M. Khanani and Caroline R. Baumal, in Retina Today
December, 2021
Topical drug delivery to the retina: obstacles and routes to success
By Thorsteinn Loftsson, published by Expert Opinion on Drug Delivery
May, 2021
Ocular Surface Disease Product Roundup: The players you need to know
Editorial Spotlight (several authors) on CRST – Cataract and Refractive Surgery Today
April, 2021
Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment
By Thorsteinn Loftsson and Einar Stefansson, published by Acta Ophthalmologica
April, 2021
The quest for topical treatments for the posterior segment
By Dr Ramin Tadayoni on Ophthalmology Times Europe